Earnings Preview: Abbott Laboratories msnbc.com Niacin is a form of vitamin B that boosts good cholesterol , which has been shown to fight artery buildup. Contrary to what researchers had hoped, that benefit didn't translate into fewer heart attacks among patients with a history of heart disease. Read more »
HDL function, independent of levels, impaired in STEMI patients – TheHeart.Org
HDL function, independent of levels, impaired in STEMI patients TheHeart.Org The Atherothrombosis Intervention in Metabolic Syndrome with Low HDL Cholesterol /High Triglyceride and Impact on Global Health Outcomes (AIM-HIGH) study of high-dose extended-release niacin (Niaspan, Abbott) given in addition to statin therapy in ... First joint ESC/EAS guidelines for the management of dyslipidaemias EurekAlert (press release) all 12 news articles?? Read more »
Will the FDA Approve Pfizer and Acura’s Acurox? – Motley Fool
Will the FDA Approve Pfizer and Acura's Acurox? Motley Fool At the time, the duo was also adding niacin to the drug to deter abuse. Read more »
Is Niaspan Necessary? New Study Raises Debate Over Use of Cholesterol Drug – openPR (press release)
Is Niaspan Necessary? New Study Raises Debate Over Use of Cholesterol Drug openPR (press release) Seattle, WA – June 10th, 2011 -- Niaspan is a cholesterol drug manufactured by Abbott Laboratories. Doctors have customarily prescribed Niacin to raise levels of HDL ("good" cholesterol ) in patients taking a statin pill that is successfully lowering ... Read more »
Abbott (ABT) Could See More Downside With Billion Dollar Cholesterol Franchise … – StreetInsider.com (subscription)
Abbott (ABT) Could See More Downside With Billion Dollar Cholesterol Franchise ... StreetInsider.com (subscription) Last week, the government's National Institutes of Health halted a trial of Abbott's Niaspan, a prescription form of niacin intended to boost good cholesterol , after the agency showed the drug failed to prevent heart attacks and strokes in patients .. Read more »
An Overreaction in Abbott, Merck Shares – Barron’s
An Overreaction in Abbott, Merck Shares Barron's There are two critical differences between AIM-HIGH and the HPS2-THRIVE Study with Merck's Tredaptive (extended-release niacin in combination with laropiprant) that leave us optimistic on Tredaptive's likelihood for success: 1) HPS2-THRIVE is much ... Read more »
Doctors rethinking prescribing Abbott’s Niaspan – Chicago Tribune
istockAnalyst.com (press release) Doctors rethinking prescribing Abbott's Niaspan Chicago Tribune ... Read more »
New NLA guidelines on the management of patients with FH – TheHeart.Org
New NLA guidelines on the management of patients with FH TheHeart.Org Patients treated with a statin who had a 50% reduction in LDL cholesterol but who still have levels > 160 mg/dL may need other drugs, such as ezetimibe (Zetia, Merck/Schering-Plough), niacin (Niaspan, Abbott), or bile-acid sequestrants. ... Read more »
FDA tells advisors to focus on ACCORD for fenofibrate review – TheHeart.Org
FDA tells advisors to focus on ACCORD for fenofibrate review TheHeart.Org But, as reported by heartwire, some experts have argued that other agents, such as niacin , are a better option to try first in these severely hypertriglyceridemic patients. Read more »
Where Are Biotech’s Billionaires? – Forbes (blog)
Forbes (blog) Where Are Biotech's Billionaires? Forbes (blog) Michael Jaharis, worth $1.9 billion, launched a company called Kos Pharmaceuticals in 1988 that developed a prescription version of the B vitamin niacin , to raise good cholesterol . It was sold to Abbott Laboratories in 2006 for $4.6 billion. Read more »
